HBK Investments »

Cytokinetics shares owned by HBK Investments

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by HBK Investments from 13F filings

Historical chart of HBK Investments investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by HBK Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by HBK Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.0M 100k 70.11

More positions owned by HBK Investments

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Hess (HES)
United Parcel Service CL B Call Option (UPS)
Exxon Mobil Corporation Call Option (XOM)
Fidelity Wise Origin Bitcoin SHS
Doordash Cl A Put Option (DASH)
Chevron Corporation Call Option (CVX)
Coinbase Global Note 0.500% 6/0 (Principal)
Synopsys Call Option (SNPS)
Anthem Call Option (ELV)
Chipotle Mexican Grill Call Option (CMG)
Kla Corp Com New Call Option (KLAC)
Tko Group Holdings Cl A Call Option (TKO)
Etf Ser Solutions Us Glb Jets Put Option (JETS)

View all positions for HBK Investments

Top funds holding Cytokinetics

BlackRock
FMR
Vanguard Group
Wellington Management Company
Bank of America Corporation
T. Rowe Price Investment Management
T. Rowe Price Associates
Marshall Wace
Pentwater Capital Management
Geode Capital Management
Armistice Capital
HAP Trading
Susquehanna International
Boxer Capital
Melqart Asset Management

View all funds holding Cytokinetics